News | March 05, 2024
Biocon Biologics secures Canada market entry date for YESAFILI
This agreement paves the way for the introduction of YESAFILI into the Canadian market
This agreement paves the way for the introduction of YESAFILI into the Canadian market
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The plant will drive pharmaceutical innovation in the Northeastern India
The facility will accommodate over 1,500 employees
The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to US$ 9.13 million
The board gave in-principle approval for expansion of company's footprint in Lucknow
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
Subscribe To Our Newsletter & Stay Updated
